• 1
    O'Sullivan BP, Freedman SD. Cystic fibrosis. Lancet 2009: 373: 1891904.
  • 2
    Fluge G, Olesen HV, Gilljam M et al. Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients. J Cyst Fibros 2009: 8: 198202.
  • 3
    Walkowiak J, Blask-Osipa A, Lisowska A et al. Cystic fibrosis is a risk factor for celiac disease. Acta Biochim Pol 2010: 57: 1158.
  • 4
    Safwenberg J, Kollberg H, Lindblom JB. HLA frequencies in patients with cystic fibrosis. Tissue Antigens 1977: 10: 28790.
  • 5
    Hennequet A, Jehanne M, Betuel H, Gilly R, Schmid M, Hors J. Cystic fibrosis and HLA. Tissue Antigens 1978: 12: 15962.
  • 6
    Turner MW, Warner JO, Stokes CR. Immunological studies in cystic fibrosis. Arch Dis Child 1978: 53: 6318.
  • 7
    Stutchfield PR, O'Halloran SM, Smith CS, Woodrow JC, Bottazzo GF, Heaf D. HLA type, islet cell antibodies, and glucose intolerance in cystic fibrosis. Arch Dis Child 1988: 63: 12349.
  • 8
    Jones MM, Seilheimer DK, Pollack MS, Curry M, Crane MM, Rossen RD. Relationship of hypergammaglobulinemia, circulating immune complexes, and histocompatibility antigen profiles in patients with cystic fibrosis. Am Rev Respir Dis 1989: 140: 16369.
  • 9
    Witt M, Erickson RP, Ober C, Howatt WF, Farber R. Correlation of phenotypic and genetic heterogeneity in cystic fibrosis: variability in sweat electrolyte levels contributes to heterogeneity and is increased with the XV-2c/KM19 B haplotype. Am J Med Genet 1991: 39: 13743.
  • 10
    Aron Y, Polla BS, Bienvenu T, Dall'ava J, Dusser D, Hubert D. HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype. Am J Respir Crit Care Med 1999: 159: 14648.
  • 11
    Duthie A, Doherty DG, Donaldson PT et al. The major histocompatibility complex influences the development of chronic liver disease in male children and young adults with cystic fibrosis. J Hepatol 1995: 23: 5327.
  • 12
    Dunbar SA. Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta 2006: 363: 7182.
  • 13
    Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G. PyPop update – a software pipeline for large-scale multilocus population genomics. Tissue Antigens 2007: 69 (Suppl 1): 1927.
  • 14
    Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992: 48: 36172.
  • 15
    van den Berg-Loonen E, Voorter C. HLA-DPB1 and -DQB1 alleles in a population from The Netherlands. Hum Immunol 2004: 65: 10312.
  • 16
    Chauhan B, Santiago L, Hutcheson PS et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000: 106: 7239.
  • 17
    De Boeck K, Wilschanski M, Castellani C et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006: 61: 62735.
  • 18
    Farrell PM, Rosenstein BJ, White TB et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008: 153: S414.
  • 19
    Dequeker E, Stuhrmann M, Morris MA et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders – updated European recommendations. Eur J Hum Genet 2009: 17: 5165.